Prostate Cancer

PROSTATE ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Alcohol and Prostate Cancer: How Is Intake Associated With Risk of Death and/or Metastasis?

This data analysis examined the effect of alcohol consumption on the risk of lethal prostate cancer in men at risk of the disease, and those who developed nonmetastatic prostate cancer during follow-up.
Self-Management in Long-Term Survivors of Prostate Cancer: Does It Work?

Although there have been significant advancements in the treatment of prostate cancer with medications, radiation, surgery and/or brachytherapy, there continue to be concerns about posttreatment side effects.
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home

Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?
What Do Surrogate End Points Actually Predict?

As understanding of cancer improves, drug development could become accelerated, necessitating a means for determining whether a drug is actually effective.
Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.

Current Research Into Pain Assessment

Immunotherapy for Prostate Cancer

Targeted Agents

Targeted Agents (cont.)

Radium-223

Chemotherapy

Immunotherapy

Treatment Sequencing

Androgen Deprivation Therapy

Duration of ADT

Docetaxel in Combination With ADT

Researchers at Johns Hopkins identified genes involved in tumor cell metabolism that may predict whi

HSD3B1 Allele Inheritance Linked With ADT Resistance

ADT and Radiation

Predictions for the Future

PROSTATE CANCER NEWS

Active Surveillance for Intermediate-Risk PCa Increasing in US

June 25, 2019

Neoadjuvant Combo Reduces Volume of High-Risk Prostate Tumors

June 21, 2019

Preventive therapy for ER-negative breast cancer

Adding Apalutamide to ADT Prolongs Survival in mCSPC

June 14, 2019

Multiparametric MRI images (coronal view) demonstrating PIRADS 5 signal abnormality in the right peripheral zone of the prostate. A PIRADS 4 lesion can also be seen in the right transitional zone.

Prostate Cancer Detection Greater With Targeted Plus Systematic Biopsy

June 14, 2019

PET CT Imaging of Prostate Cancer

PET/CT Imaging for Recurrent PCa Detection More Accurate With PSMA

June 14, 2019

Next post in Prostate Cancer

Active Surveillance for Intermediate-Risk PCa Increasing in US